CD269 (BCMA) ANTIGEN EXPRESSION IN PATIENTS WITH SYSTEMIC AL-A.

EHA Library, Nelly Kashchavtseva, 4161968

BELANTAMAB MAFODOTIN + POMALIDOMIDE + DEXAMETHASONE (BPD) VS DARATUMUMAB + BORTEZOMIB + DEXAMETHASONE (DVD) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: AN INDIRECT COMPARISON USING PATIENT-LEVEL DATA

EHA Library, Meral Beksac, 4161969

ANALYSIS OF THE PRELIMINARY RESULTS OF A PILOT REAL-WORLD STUDY OF APONERMIN COMBINED WITH KT-DECP REGIMEN IN RELAPSED/REFRACTORY MULTIPLE MYELOMA WITH PLASMACYTOMA

EHA Library, Aijun Liu, 4161970

CLINICAL ASSAY FOR PRECISION DIAGNOSIS, MONITORING AND INFORMING THERAPY OF MULTIPLE MYELOMA USING BONE MARROW OR PERIPHERAL BLOOD

EHA Library, Francois Aguet, 4161971

COMPARISON OF DIFFERENT CYCLOPHOSPHAMIDE DOSES FOR HEMATOPOIETIC STEM CELL MOBILIZATION IN MULTIPLE MYELOMA: A RETROSPECTIVE STUDY

EHA Library, Mehmet Sinan Dal, 4161972

QUANTITATIVE RISK OF UNDERLYING DISEASE CONDITIONS FOR PROGRESSION FROM MONOCLONAL GAMMOPATHY TO MULTIPLE MYELOMA: A NATIONWIDE COHORT STUDY

EHA Library, suein choi, 4161973

REAL-WORLD DURATION OF TREATMENT IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (MM) RECEIVING THE PROTEASOME INHIBITOR IXAZOMIB THROUGH THE GLOBAL IXAZOMIB EXPANDED ACCESS PROGRAM (EAP)

EHA Library, Efstathios Kastritis, 4161974

IXAZOMIB-BASED MAINTENANCE THERAPY IN REAL-WORLD PRACTICE FOR NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS

EHA Library, Liye Zhong, 4161975

EMERGING CARE MODELS OF TECLISTAMAB STEP-UP DOSING ADMINISTRATION IN REAL WORLD CLINICAL PRACTICE

EHA Library, Benjamin Derman, 4161976

TEMPORAL TRENDS IN ECOG PERFORMANCE SCORES IN MULTIPLE MYELOMA PATIENTS: A SIX-YEAR (2019-2024) RETROSPECTIVE ANALYSIS WITHIN THE EU4+UK MARKETS

EHA Library, Alessandra Franceschetti, 4161977

REAL-WORLD CHARACTERISTICS, TREATMENT, AND OUTCOMES IN MULTIPLE MYELOMA PATIENTS ON SECOND-LINE THERAPY: A MULTICENTER STUDY USING NATURAL LANGUAGE PROCESSING AND MACHINE LEARNING

EHA Library, Joaquín Martínez-López, 4161978

RAD21 SERVES AS A PROGNOSTIC INDICATOR IN MULTIPLE MYELOMA AND IS ASSOCIATED WITH HIGH-RISK GENETIC BACKGROUNDS

EHA Library, Yanling Wu, 4161980

OPTIMIZING BELANTAMAB MAFODOTIN IN TRIPLE-CLASS REFRACTORY MULTIPLE MYELOMA: IMPACT OF DOSE MODIFICATIONS ON KERATOPATHY INCIDENCE IN A REAL-WORLD RETROSPECTIVE STUDY

EHA Library, Lina Rüsing, 4161981

RIVAROXABAN FOR THE PREVENTION OF THROMBOEMBOLISM IN IMID-CONTAINING MYELOMA TREATMENT REGIMENS

EHA Library, Jamie Maddox, 4161982

PROSPECTIVE, SYSTEMATIC CLASSIFICATION OF CAUSES OF DEATH IN THE COURSE OF MULTIPLE MYELOMA

EHA Library, Jia xiang Jin, 4161983

SELECTION OF TREATMENT PLANS FOR PATIENTS WITH NEWLY-DIAGNOSED MULTIPLE MYELOMA WITH RENAL IMPAIRMENT IN NOVEL AGENTS ERA: A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Shaoxue Ding, 4161984

REAL-WORLD TREATMENT (TX) PATTERNS AND OUTCOMES IN PATIENTS (PTS) WITH MULTIPLE MYELOMA (MM): INSIGHTS FROM ARGENTINA AND BRAZIL (2018-2024)

EHA Library, Vania Hungria, 4161985

SECONDARY CLONES IDENTIFIED BY MASS SPECTROMETRY IN BASELINE SAMPLES REMAIN STABLE OR DISAPPEAR EARLY DURING MONITORING IN MULTIPLE MYELOMA PATIENTS

EHA Library, Oscar Berlanga, 4161986

IMPACT OF CUMULATIVE DOSE OF LENALIDOMIDE IN HEMATOLOGICAL PATIENTS ON THE DEVELOPMENT OF SECONDARY NEOPLASMS.

EHA Library, Gerardo Aguilar Monserrate, 4161987

FEATURES OF THE MOLECULAR LANDSCAPE OF MULTIPLE MYELOMA

EHA Library, Daria Chebykina, 4161988

CAN MITOCHONDRIAL DNA COPY NUMBER AND LEUKOCYTE TELOMERE LENGTH BE EFFECTIVE IN THE PROGNOSIS OF MULTIPLE MYELOMA?

EHA Library, Hasim Erol, 4161989

FROM MGUS TO MALIGNANCY: PROGNOSTIC FACTORS AND CLINICAL IMPLICATIONS

EHA Library, Aleksandra Sretenovic, 4161990

COMPARATIVE SAFETY OUTCOMES OF BCMA-DIRECTED VS. NON-BCMA BISPECIFIC ANTIBODIES IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Abat Khan, 4161991

AN INDIRECT COMPARISON OF ELRANATAMAB'S PATIENT-REPORTED OUTCOMES FROM MAGNETISMM-3 VERSUS REAL-WORLD EXTERNAL CONTROL ARMS IN TRIPLE-CLASS REFRACTORY MULTIPLE MYELOMA

EHA Library, Benjamin Hebraud, 4161992

CHRONIC HEPATITIS E INFECTIONS IN MULTIPLE MYELOMA: A HIDDEN THREAT IN THE ERA OF CAR-T AND BISPECIFIC ANTIBODIES

EHA Library, Ricardo Kosch, 4161993

DIAGNOSTIC VALUE OF 2D-STI ECHOCARDIOGRAPHIC MODEL IN MULTIPLE MYELOMA COMPLICATED WITH CARDIAC AMYLOIDOSIS

EHA Library, Chengcheng Fu, 4161994

THE SIGNIFICANCE OF A MGUS TUMOR BOARD: UPDATES AFTER THREE YEARS OF SUCCESS

EHA Library, Sandy Mazzoni, 4161995

EFFICACY AND SAFETY OF TALQUETAMAB AMONG HEAVILY PRE-TREATED PATIENTS WITH RELAPSED REFRACTORY MULTIPLE MYELOMA IN THE EXPANDED ACCESS PROGRAM AND COMMERCIAL SETTING

EHA Library, Sandy Mazzoni, 4161996

EPIDEMIOLOGY AND DISEASE ASSOCIATIONS OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE IN TAIWAN: A RETROSPECTIVE STUDY

EHA Library, Chao-Hung Wei, 4161997

CONCORDANCE BETWEEN BLINDED INDEPENDENT CENTRAL REVIEW COMMITTEE AND PHYSICIAN-ASSESSED RESPONSES, BASED ON A REAL-WORLD EXTERNAL CONTROL ARM IN RELAPSED/REFRACTORY MULTIPLE MYELOMA USING IMWG DATA

EHA Library, Brian G. Durie, 4161998

INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS AND ANALYSIS OF RISK FACTORS IN NEWLY ADMITTED PATIENTS WITH MULTIPLE MYELOMA

EHA Library, gongqiang wu, 4161999

MAGNETISMM-32: A PHASE 3 RANDOMIZED STUDY OF ELRANATAMAB VS EPD, PVD, OR KD IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) AND PRIOR ANTI-CD38-DIRECTED THERAPY

EHA Library, Thomas Chalopin, 4162000

YEAR-OVER-YEAR ONLINE MULTIPLE MYELOMA CURRICULUM IMPROVES THE COMPREHENSIVE MANAGEMENT SKILLS OF HEMATOLOGIST/ONCOLOGISTS

EHA Library, Sarah Elizabeth Bomba, 4162002

FAMILIAL MULTIPLE MYELOMA: CASE REPORT AND WHOLE EXOME SEQUENCING ANALYSIS

EHA Library, Yuanyuan Shao, 4162003

REAL-WORLD EFFICACY AND SAFETY OF POMALIDOMIDE-BASED TRIPLET THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: A MULTICENTER RETROSPECTIVE COHORT ANALYSIS

EHA Library, Li Bao, 4162005

ASSOCIATION OF DARATUMUMAB-BASED TREATMENT DURATION WITH REAL-WORLD SURVIVAL OUTCOMES IN CHINESE PATIENTS WITH MULTIPLE MYELOMA: EXPLORATORY ANALYSIS OF THE MMY4032 STUDY

EHA Library, Jin Lu, 4162006

COUNTRY VARIATIONS IN TREATMENT GOALS, EXPECTATIONS, AND EXPERIENCES AMONG PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

EHA Library, Albert Oriol, 4162007

THE PROGNOSTIC VALUE OF RED BLOOD CELL DISTRIBUTION WIDTH IN AL AMYLOIDOSIS

EHA Library, Despina Fotiou, 4162008

BELANTAMAB MAFODOTIN, BORTEZOMIB, AND DEXAMETHASONE VS DARATUMUMAB, BORTEZOMIB, AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: ANALYSIS OF THE CHINA SUBPOPULATION IN THE DREAMM-7 STUDY

EHA Library, Chengcheng Fu, 4162009

TREATMENT PATTERNS AT FIRST RELAPSE AND THEIR OUTCOMES IN MULTIPLE MYELOMA; A FINNISH RWD STUDY

EHA Library, Juha Lievonen, 4162010

REAL-WORLD TREATMENT PATTERNS AND CLINICAL OUTCOMES AMONG TRIPLE-CLASS-EXPOSED (TCE) PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) AND EXTRAMEDULLARY DISEASE (EMD)

EHA Library, Hans Lee, 4162011

REAL-WORLD TREATMENT PATTERNS AND OUTCOMES OF TRIPLE CLASS EXPOSED (TCE) PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED IN COMMUNITY AND ACADEMIC ONCOLOGY PRACTICES IN THE US

EHA Library, Saulius Girnius, 4162012

PAIN AND MULTIPLE MYELOMA: A THERAPEUTIC SYNERGY FOR IMPROVED QUALITY OF LIFE

EHA Library, Faten kallel, 4162013

DYNAMIC CHANGES OF PERIPHERAL BLOOD MONOCYTIC MYELOID-DERIVED SUPPRESSOR CELLS (MMDSCS) IN MULTIPLE MYELOMA

EHA Library, Li Bao, 4162014

LET'S GET TO THE HEART OF THE MATTER: EXAMINING THE PREVALENCE AND PREDICTORS OF CARDIOVASCULAR DISEASE IN MULTIPLE MYELOMA IN A LARGE REAL-WORLD DATASET

EHA Library, Romi Carriere, 4162015

MAINTENANCE THERAPY FOLLOWED AUTOLOGOUS STEM CELL TRANSPLANTATION BY IXAZOMIB,LENALIDOMIDE,OR IXAZOMIB IN COMBINATION WITH LENALIDOMIDE IN PATIENTS WITH MULTIPLE MYELOMA: A MULTI-CENTERED STUDY IN CHINA

EHA Library, Minqiu Lu, 4162017

REAL-WORLD DATA ON BRIDGING STRATEGIES, TOXICITY AND OUTCOMES OF RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED WITH CAR-T-CELLS

EHA Library, Jule Artzenroth, 4162018

VALIDATION AND REAL-WORLD APPLICATION OF THE NOVEL HIGH-RISK MULTIPLE MYELOMA CRITERIA BY THE IMS/IMWG CONSENSUS

EHA Library, Charalampos Filippatos, 4162019

EFFICACY AND SAFETY OF BELANTAMAB MAFODOTIN IN RR MULTIPLE MYELOMA, EXPERIENCE OF TUSCAN MYELOMA NETWORK

EHA Library, Sara Ciofini, 4162021

AUTO-BCMA-CART CELLS AS THE FIRST LINE MAINTENANCE THERAPY FOR MULTIPLE MYELOMA

EHA Library, Rong Fu, 4162022

EVALUATION OF DISEASE CHARACTERISTICS, TREATMENT STRATEGIES, AND OUTCOMES OF PATIENTS WITH EXTRAMEDULLARY MULTIPLE MYELOMA

EHA Library, Francesca Cottini, 4162023

LONG-TERM FOLLOW-UP FROM THE CHINA COHORT OF THE PHASE 1/2 MAJESTEC-1 STUDY OF TECLISTAMAB (TEC) TREATMENT IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

EHA Library, Juan Du, 4162024

THE CLINICAL SIGNIFICANCE OF IMMUNOGLOBULIN CLONAL ISOTYPE SWITCHING IN PATIENTS WITH MULTIPLE MYELOMA AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Lijing Shen, 4162025

THE IRD REGIMEN CONTINUED AFTER EFFECTIVE INDUCTION WITH DRD FOR TRANSPLANT-INELIGIBLE PATIENTS WITH MULTIPLE MYELOMA: A MULTI-CENTER PROSPECTIVE STUDY IN CHINA

EHA Library, Li Bao, 4162026

REAL-WORLD CLINICAL OUTCOMES OF DARATUMUMAB-BASED REGIMENS IN CHINESE PATIENTS WITH MULTIPLE MYELOMA BY RISK FACTOR: AN EXPLORATORY SUBGROUP ANALYSIS OF THE MMY4032 STUDY

EHA Library, Jin Lu, 4162027

IMPROVING DIAGNOSIS AND TREATMENT OF AL AMYLOIDOSIS IN THE CURRENT ERA: A SINGLE CENTRE RETROSPECTIVE ANALYSIS

EHA Library, NITIN GUPTA, 4162028

DIAGNOSTIC VALUE OF BORDERLINE SERUM FREE LIGHT CHAIN RATIO - SINGLE CENTER ANALYSIS

EHA Library, Jakub Radocha, 4162029

EXPLORING TUMOR-EDUCATED PLATELETS (TEPS) AS A NOVEL BIOMARKER SOURCE FOR MULTIPLE MYELOMA

EHA Library, Ana Bela Sarmento-Ribeiro, 4162031

ANALYSIS OF PROGNOSTIC FACTORS AFFECTING THE EFFICACY OF BCMA-TARGETED CAR-T THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Yi Wang, 4162032

AMBULATORY THROMBOPROPHYLAXIS AND INCIDENCE OF THROMBOSIS IN PATIENTS WITH MULTIPLE MYELOMA: A SECONDARY CARE CENTRE EXPERIENCE

EHA Library, Benjamin Lau, 4162033

VERIFICATION AND OPTIMIZATION OF VTE RISK STRATIFICATION SYSTEM FOR MULTIPLE MYELOMA IN CHINA BASED ON REVIEW COHORT

EHA Library, yuexiao liu, 4162034

REAL-WORLD COMPARISON OF TREATMENT OUTCOMES FOR MYELOMA IN ELDERLY TRANSPLANT INELIGIBLE PATIENTS RECEIVING FIRST-LINE VRD, RD AND VCD: RESULTS FROM THE ANZ MYELOMA AND RELATED DISEASES REGISTRY

EHA Library, Sarah Zhao, 4162035

WORSE SURVIVAL OUTCOME IN NEW ZEALAND PATIENTS WITH MULTIPLE MYELOMA COMPARING AUSTRALIA - A RETROSPECTIVE COHORT STUDY FROM THE MYELOMA AND RELATED DISEASES REGISTRY (MRDR)

EHA Library, Jian Li, 4162036

EARLY TREATMENT DISCONTINUATION (ETD) OR DEATH (ED) IN MULTIPLE MIELOMA PATIENTS TREATED FRONT-LINE WITH BORTEZOMIB, LENALIDOMIDE AND DEXAMETHASONE (VRD)

EHA Library, Gladys Ibarra, 4162038

GLUD1 IS HIGHLY EXPRESSED IN NEWLY DIAGNOSED MULTIPLE MYELOMA AND PROMOTES DISEASE PROGRESSION

EHA Library, Qiuwen Mi, 4162039

THE VALUE OF PERIPHERAL BLOOD LYMPHOCYTE SUBSETS IN PREDICTING THE PROGNOSIS OF NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Rong Fu, 4162040

THE EFFICACY OF ELRANATAMAB IN MAGNETISMM-3 COMPARED WITH A REAL-WORLD CONTROL ARM SIMULATING A COLOMBIAN TRIPLE-CLASS REFRACTORY MULTIPLE MYELOMA POPULATION

EHA Library, Juan Manuel Reyes, 4162042

CLINICAL OUTCOMES OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA OVERALL AND AMONG LENALIDOMIDE-REFRACTORY PATIENTS IN EAST ASIA: A TARGETED LITERATURE REVIEW

EHA Library, Yi Tao, 4162043

D-VRD IN NEWLY DIAGNOSED MULTIPLE MYELOMA IN CHINA: A MULTICENTER REAL-WORLD STUDY COMPARING EFFICACY AND SAFETY WITH THE VRD REGIMEN

EHA Library, Yue Wu, 4162044

COMPARISON OF EFFICACY AND SAFETY BETWEEN IXAZOMIB BASED AND LENALIDOMIDE BASED INDUCTION IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Yan Wang, 4162045

CLINICAL CHARACTERISTICS OF 44 CHINESE PATIENTS WITH IGM-TYPE MULTIPLE MYELOMA: A MULTICENTER, RETROSPECTIVE, OBSERVATIONAL STUDY

EHA Library, Meilan Chen, 4162046

BCMA/GPRC5D BISPECIFIC CAR T-CELL THERAPY FOLLOWING APATINIB BRIDGING TREATMENT IN RELAPSED/REFRACTORY MULTIPLE MYELOMA WITH EXTRAMEDULLARY DISEASE: A SINGLE-ARM, SINGLE-CENTER PHASE 1 TRIAL

EHA Library, Ling Qiu, 4162047

A JOURNEY THROUGH UNDERSTANDING AND MANAGING WALDENSTROMS MACROGLOBULINEMIA (WM): 13 YEARS OF INSIGHT

EHA Library, Dibakar Podder, 4162048

DETERMINATION OF THE BIOLOGICAL VARIATION OF SOLUBLE B-CELL MATURATION ANTIGEN

EHA Library, Oscar Berlanga, 4162049

SUPPORTING TREATMENT DECISION-MAKING FOR LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA PATIENTS POST-DRD IN ITALY: A MULTI-CRITERIA DECISION FRAMEWORK

EHA Library, Mario Boccadoro, 4162050

REAL-LIFE EXPERIENCE WITH FIRST-LINE TREATMENT WITH DARATUMUMAB-BASED THERAPY IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA INELIGIBLE FOR AUTOLOGOUS STEM-CELL TRANSPLANTATION.

EHA Library, Francesca Fazio, 4162051

TRIAL IN PROGRESS: PHASE 1B, DOSE ESCALATION/DOSE EXPANSION STUDY OF OPN-6602 MONOTHERAPY AND IN COMBINATION WITH DEXAMETHASONE IN SUBJECTS WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA

EHA Library, Andrew Sochacki, 4162052

PRE-DIAGNOSTIC ROUTINE LABORATORY TESTING PATTERNS IN PEOPLE WITH MULTIPLE MYELOMA REFERRED TO A TERTIARY SOUTH AFRICAN HOSPITAL

EHA Library, Ryan Aylward, 4162053

A NON-INTERVENTIONAL, PROSPECTIVE, POST-AUTHORIZATION SAFETY STUDY IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH CILTACABTAGENE AUTOLEUCEL: TRIAL IN PROGRESS

EHA Library, Ralph Wäsch, 4162054

DOES INCORPORATING ANTI-CD38 ANTIBODIES TO THE FIRST LINE TREATMENT FOR MULTIPLE MYELOMA HAVE ANY IMPACT ON EARLY MORTALITY? EXPERIENCE OF A SINGLE CENTER.

EHA Library, Sunil Lakhwani, 4162055

SUCCESSFUL EARLY RESCUE WITH ISATUXIMAB PLUS CARFILZOMIB-DEXAMETHASONE (ISA-KD) IN DARATUMUMAB-REFRACTORY NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH „NO WASHOUT PERIOD”.

EHA Library, Paula Gili Herreros, 4162056

FIRST-IN-HUMAN, OPEN-LABEL, PHASE 1 TRIAL DESIGN OF SAR446523, A NOVEL ANTI-GPRC5D ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY (ADCC)-ENHANCED MONOCLONAL ANTIBODY FOR MULTIPLE MYELOMA

EHA Library, Prashant Kapoor, 4162057

TRANSGELIN-2 AS A PROGNOSTIC MARKER IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH RENAL DAMAGE.

EHA Library, Rasha Mohamed Said, 4162058

CHARACTERISTICS AND TREATMENT PATTERNS IN PATIENTS WITH MULTIPLE MYELOMA: A REAL-WORLD RETROSPECTIVE STUDY IN JAPAN USING ELECTRONIC HEALTH RECORDS

EHA Library, Nami Tagami, 4162059

TRIAL IN PROGRESS: QUINTESSENTIAL-2—A PHASE 3 STUDY OF ARLOCABTAGENE AUTOLEUCEL VERSUS STANDARD OF CARE IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) REFRACTORY TO LENALIDOMIDE

EHA Library, Rakesh Popat, 4162060

OVERCOMING PRIMARY RESISTANCE TO ANTI-BCMA BISPECIFIC ANTIBODY THERAPY THROUGH MULTIMODAL SBCMA DEBULKING IN A PATIENT WITH TRIPLE EXPOSURE TO TECLISTAMAB

EHA Library, Sven Neubert, 4162062

CARFILZOMIB, POMALIDOMIDE, DEXAMETHASONE WITH AND WITHOUT DARATUMUMAB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: A MULTI-CENTER, PROSPECTIVE REAL WORLD STUDY IN CHINA

EHA Library, Fujing Zhang, 4162063

P-SELECTIN AND SST2 IN PROGNOSIS OF CARDIOVASCULAR EVENTS IN PATIENTS WITH MULTIPLE MYELOMA AFTER ANTINEOPLASTIC TREATMENT AND SEVERE COVID-19

EHA Library, Borys Samura, 4162064

TRENDS IN CLINICAL CHARACTERISTICS, TREATMENT PATTERNS AND SURVIVAL OUTCOMES OF PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): A SINGLE CENTER REAL WORLD DATA OF OVER 12 YEARS

EHA Library, Mamta Garg, 4162065

LONG-TERM SURVIVAL IN MULTIPLE MULTIPLE MYELOMA PATIENTS: A SINGLE-CENTRE STUDY

EHA Library, Pedro Pinho Moura, 4162067

IMPLEMENTING A COMPETITIVE FUNDING SCHEME FOR ADVANCING THE QUALITY OF CARE FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING TREATMENT WITH BISPECIFIC ANTIBODIES.

EHA Library, Joseph Mikhael, 4162068

REAL-WORLD EVALUATION OF DARATUMUMAB, BORTEZOMIB, LENALIDOMIDE, AND DEXAMETHASONE (D-VRD) INDUCTION FOLLOWED BY DARATUMUMAB AND LENALIDOMIDE (DR) MAINTENANCE IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA

EHA Library, Joao Tadeu Souto Filho, 4162069

A PHASE I/IIA STUDY TO EVALUATE INOBRODIB IN PATIENTS WITH ADVANCED HEMATOLOGICAL MALIGNANCIES: DOSE EXPANSION COHORTS OF INOBRODIB IN COMBINATION WITH POMALIDOMIDE/DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Emma Searle, 4162070

EFFICACY AND SAFETY OF SELINEXOR, CARFILZOMIB, POMALIDOMIDE AND DEXAMETHASONE IN THE TREATMENT OF MULTIPLE MYELOMA WITH EXTRAMEDULLARY DISEASE: A PROSPECTIVE MULTI-CENTER SINGLE-ARM STUDY

EHA Library, Hai Zhou, 4162071

TRIAL IN PROGRESS: PHASE I/II STUDY OF MEZIGDOMIDE AND ELRANATAMAB FOR RELAPSED/ REFRACTORY MULTIPLE MYELOMA PATIENTS (MELT-MM)

EHA Library, Ja Min Byun, 4162072

UNVEILING OSTEOPOROSIS IN PATIENTS DIAGNOSED WITH MGUS.IS THERE A NEED OF INTERVENTION?THE EXPERIENCE OF OUR DEPARTMEN AND VA BRIEF REVIEW.

EHA Library, THEOFANIA PETRA, 4162073

A REAL-WORLD STUDY ON THE EFFICACY AND SAFETY OF POMALIDOMIDE AS MAINTENANCE THERAPY FOR PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Ling Qin, 4162074

MISSED OPPORTUNITIES IN AL AMYLOIDOSIS: HOW E' VELOCITY, PERICARDIAL EFFUSION BIOMARKERS, AND DELAYED AMYLOID TYPING IMPACT ASTCT ELIGIBILITY

EHA Library, Sabina Loredana Georgiana Olteanu, 4162075

CYTOGENETIC ANALYSIS OF MULTIPLE MYELOMA PATIENTS: SINGLE CENTER REPORT

EHA Library, Iva Semren, 4162076

SOCIAL DETERMINANTS OF HEALTH, TRANSITION OF CARE, AND OUTCOMES AMONG REAL-WORLD RELAPSED REFRACTORY MULTIPLE MYELOMA (RRMM) PATIENTS TREATED WITH TECLISTAMAB

EHA Library, Amir Ali, 4162077